Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer

M. Klain, S. Maurea, S. Lastoria, A. Cuocolo, A. Colao, M. Salvatore

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

This report describes the accurate localization of metastatic lesions in a patient with differentiated mixed thyroid cancer using 99mTc-tetrofosmin imaging. A 66-yr-old women with a cytological diagnosis of follicular thyroid cancer associated with a large amount of goiter changes was studied by 99mTc-tetrofosmin total-body scintigraphy. No significant tetrofosmin uptake was observed in the thyroid nodules, which mainly showed goiter abnormalities. Abnormal increased tetrofosmin uptake, however, was found in metastatic tumor lesions located in the cervical and dorsal spine as well as in the left lower chest wall and lungs. In conclusion, 99mTc-tetrofosmin, a new radiopharmaceutical proposed for myocardial perfusion imaging, may be useful in patients with thyroid cancer.

Original languageEnglish
Pages (from-to)2248-2251
Number of pages4
JournalJournal of Nuclear Medicine
Volume36
Issue number12
Publication statusPublished - 1995

Fingerprint

Thyroid Neoplasms
Goiter
Thyroid Nodule
Myocardial Perfusion Imaging
Radiopharmaceuticals
Thoracic Wall
Radionuclide Imaging
Spine
Lung
technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane
Neoplasms

Keywords

  • metastasis
  • technetium-99m-tetrofosmin
  • thyroid cancer
  • total-body imaging

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer. / Klain, M.; Maurea, S.; Lastoria, S.; Cuocolo, A.; Colao, A.; Salvatore, M.

In: Journal of Nuclear Medicine, Vol. 36, No. 12, 1995, p. 2248-2251.

Research output: Contribution to journalArticle

Klain, M. ; Maurea, S. ; Lastoria, S. ; Cuocolo, A. ; Colao, A. ; Salvatore, M. / Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer. In: Journal of Nuclear Medicine. 1995 ; Vol. 36, No. 12. pp. 2248-2251.
@article{09511ba6278c4030aebac098147b5bb6,
title = "Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer",
abstract = "This report describes the accurate localization of metastatic lesions in a patient with differentiated mixed thyroid cancer using 99mTc-tetrofosmin imaging. A 66-yr-old women with a cytological diagnosis of follicular thyroid cancer associated with a large amount of goiter changes was studied by 99mTc-tetrofosmin total-body scintigraphy. No significant tetrofosmin uptake was observed in the thyroid nodules, which mainly showed goiter abnormalities. Abnormal increased tetrofosmin uptake, however, was found in metastatic tumor lesions located in the cervical and dorsal spine as well as in the left lower chest wall and lungs. In conclusion, 99mTc-tetrofosmin, a new radiopharmaceutical proposed for myocardial perfusion imaging, may be useful in patients with thyroid cancer.",
keywords = "metastasis, technetium-99m-tetrofosmin, thyroid cancer, total-body imaging",
author = "M. Klain and S. Maurea and S. Lastoria and A. Cuocolo and A. Colao and M. Salvatore",
year = "1995",
language = "English",
volume = "36",
pages = "2248--2251",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer

AU - Klain, M.

AU - Maurea, S.

AU - Lastoria, S.

AU - Cuocolo, A.

AU - Colao, A.

AU - Salvatore, M.

PY - 1995

Y1 - 1995

N2 - This report describes the accurate localization of metastatic lesions in a patient with differentiated mixed thyroid cancer using 99mTc-tetrofosmin imaging. A 66-yr-old women with a cytological diagnosis of follicular thyroid cancer associated with a large amount of goiter changes was studied by 99mTc-tetrofosmin total-body scintigraphy. No significant tetrofosmin uptake was observed in the thyroid nodules, which mainly showed goiter abnormalities. Abnormal increased tetrofosmin uptake, however, was found in metastatic tumor lesions located in the cervical and dorsal spine as well as in the left lower chest wall and lungs. In conclusion, 99mTc-tetrofosmin, a new radiopharmaceutical proposed for myocardial perfusion imaging, may be useful in patients with thyroid cancer.

AB - This report describes the accurate localization of metastatic lesions in a patient with differentiated mixed thyroid cancer using 99mTc-tetrofosmin imaging. A 66-yr-old women with a cytological diagnosis of follicular thyroid cancer associated with a large amount of goiter changes was studied by 99mTc-tetrofosmin total-body scintigraphy. No significant tetrofosmin uptake was observed in the thyroid nodules, which mainly showed goiter abnormalities. Abnormal increased tetrofosmin uptake, however, was found in metastatic tumor lesions located in the cervical and dorsal spine as well as in the left lower chest wall and lungs. In conclusion, 99mTc-tetrofosmin, a new radiopharmaceutical proposed for myocardial perfusion imaging, may be useful in patients with thyroid cancer.

KW - metastasis

KW - technetium-99m-tetrofosmin

KW - thyroid cancer

KW - total-body imaging

UR - http://www.scopus.com/inward/record.url?scp=0028807476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028807476&partnerID=8YFLogxK

M3 - Article

C2 - 8523115

AN - SCOPUS:0028807476

VL - 36

SP - 2248

EP - 2251

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -